Research Associate or Scientist I / Scientist II, Molecular Biology & Cell Culture


We are seeking an enthusiast researcher to work in the development of novel therapeutics harnessing the immune system to eliminate cancer. You will help guide the scientific direction of research and identify novel therapeutics. You will advance the pipeline through antibody discovery and engineering in order to produce and identify superior development candidates.



About Amphivena

Amphivena Therapeutics, Inc. is a cancer immunotherapy company based in South San Francisco, CA that is developing proprietary first-in-class, T-cell redirecting bispecific antibody-based proteins for the treatment of cancer. The company’s lead drug candidate is AMV564, a CD33/ CD3 targeting bispecific that is currently in clinical trials for acute myeloid leukemia (AML) and myelodysplastic syndromes (MDS).

Amphivena’s mission is to eradicate cancers with breakthrough therapies that harness the patient’s own immune system to destroy tumor cells and their precursors. Our aim is to restore the cellular balance needed for proper blood formation, function and circulation, restoring the flow of life to patients.

error: Content is protected !!